• Explore /
  • Poster
  • / Phase Ib/randomized phase II study combining hepatic percutaneous perfusion with ipilimumab plus nivolumab in advanced uveal melanoma: The CHOPIN trial.

Phase Ib/randomized phase II study combining hepatic percutaneous perfusion with ipilimumab plus nivolumab in advanced uveal melanoma: The CHOPIN trial.

Abstract Video & Slides Poster

Authors

null

Thaïs M.L. Tong

Leiden University Medical Center, Department of Medical Oncology/Radiology, Leiden, Netherlands

Thaïs M.L. Tong , Mark C. Burgmans , Monique Van der Kooij , Frank M. Speetjens , Arian R. van Erkel , Rutger W. van der Meer , Shelley van den Bosch , Mare A. Jonker , Inge C.F.M. Roozen , Jacob Lutjeboer , Fenna Rijksen , Els L. van Persijn-van Meerten , Chris H. Martini , Remco W.M. Zoethout , Fred G.J. Tijl , Christian U. Blank , Ellen Kapiteijn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04283890

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS9595)

DOI

10.1200/JCO.2021.39.15_suppl.TPS9595

Abstract #

TPS9595

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Thaïs M.L. Tong

First Author: Roger Olofsson Bagge

First Author: Michael B. Atkins

Poster

2020 ASCO Virtual Scientific Program

Phase II study of nivolumab and ipilimumab for advanced rare genitourinary cancers.

Phase II study of nivolumab and ipilimumab for advanced rare genitourinary cancers.

First Author: Bradley Alexander McGregor